A large health-system study found a small decrease in benzodiazepine prescription fills during the early pandemic. The result describes dispensing patterns within that system, rather than changes in individual consumption or impairment.
The comparison behind the finding
Hirschtritt and colleagues used Kaiser Permanente Northern California records for 2,405,824 adults. They examined the 13 weeks before and after the first known California COVID-19-related death on March 4, 2020, with prior-year patterns included in the analysis.
The adjusted relative risk ratio for benzodiazepine fills was 0.95, with a 95% confidence interval of 0.94–0.96. Hypnotic fills also decreased slightly, while medication classes differed. The study distinguished new from continued fills rather than treating all prescriptions as new treatment.
What a fill does and does not establish
A pharmacy fill records a dispensing event. It does not demonstrate that a patient swallowed each dose, used the drug on a particular day, or had a specified blood concentration. Changes in access, initiation of care, and continued treatment can all affect aggregate fills.
The authors did not examine dose changes or fill frequency. Broad medication classes could also obscure changes in specific agents. Continuous coverage requirements and the early-pandemic observation period limit generalization.
Using the result in a forensic discussion
The study challenges an assumption that greater reported distress necessarily produced more benzodiazepine dispensing in every setting. It does not resolve what happened to an individual patient, uninsured people, or populations outside the health system.
When discussing prescription history, identify whether the evidence concerns a prescription, a fill, reported use, or analytical detection. These categories support different inferences. The reported risk ratio is a population prescribing-pattern estimate, not a measure of intoxication or unsafe behavior.
Source
Based on the supplied paper: Psychotropic medication prescribing during the COVID 19 pandemic. PMC8556031.
Leave a Reply